KMC Speciality Hospitals Q1 FY27 results: strong YoY growth in revenue and profit

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.6%Reaction day

₹124.30

prior close

₹133.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+7.6% vs market

Hospital peers, median of 26sector+0.3%+7.3% vs sector

On the reaction day the stock moved 7.6 pts more than Nifty Microcap 250 and 7.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.0

10m

-0.2

15m

-1.2

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.6+0.1+7.6+0.3+7.3

Next day

—+0.2—-0.3—

—+0.6—-0.3—

—-0.0—-0.2—

—+0.5—+0.2—

—+0.8—-1.1—

—+0.6—-0.2—

15d

—+1.3—+0.1—

—-1.4—-1.6—

—-0.6—-11.0—

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KMC Speciality Hospitals Q1 FY27 total income Rs. 9,171.72 lakhs vs Rs. 6,435.61 lakhs in Q1 FY26, about 42% growth. PBT rose to Rs. 2,243.82 lakhs from Rs. 1,000.62 lakhs. PAT climbed to Rs. 1,591.25 lakhs from Rs. 736.61 lakhs (around 116% YoY growth). EPS Rs. 2.87 annualised vs Rs. 0.46 prior year. Deloitte Haskins and Sells issued an unmodified limited review report.

Likely market impact

Strong quarter with over 100% YoY PAT growth signals robust performance; likely positive for the stock.